-+ 0.00%
-+ 0.00%
-+ 0.00%

PTC THERAPEUTICS ANNOUNCES FDA APPROVAL OF SEPHIENCE™ (SEPIAPTERIN) FOR THE TREATMENT OF CHILDREN AND ADULTS LIVING WITH PHENYLKETONURIA (PKU)

Reuters·07/28/2025 20:19:02

Please log in to view news